Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism Chaperonin inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic breast cancer | Preclinical | US | - | |
Metastatic breast cancer | Preclinical | US | - |